Local injection of OK432 can augment the TH1-type T-cell response in tumor-draining lymph node cells and increase their immunotherapeutical potential.

T Okamoto; M Harada; K Tamada; H Yoshida; O Ito; Y Y Kong; M Takenoyama; C Hirashima; G Matsuzaki; K Nomoto

doi:10.1002/(sici)1097-0215(19970304)70:5<598::aid-ijc18>3.0.co;2-9

Local injection of OK432 can augment the TH1-type T-cell response in tumor-draining lymph node cells and increase their immunotherapeutical potential.

Identifier:nobleid.org/w1/20260515/C6DB01BC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C6DB01BC.svg?ark=w1%2F20260515%2FC6DB01BC)](https://nobleid.org/work/w1/20260515/C6DB01BC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Local injection of OK432 can augment the TH1-type T-cell response in tumor-draining lymph node cells and increase their immunotherapeutical potential.

Identifier:nobleid.org/w1/20260515/C6DB01BC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C6DB01BC.svg?ark=w1%2F20260515%2FC6DB01BC)](https://nobleid.org/work/w1/20260515/C6DB01BC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work